PharmaCom BioVet, Inc. (PHMB) は上場企業です ヘルスケア セクターの Medical - Care Facilities 業界で事業展開. 本社所在地は Raleigh, NC, アメリカ. 現CEOは Ira Frohman.
PHMB を有する IPO日 1999-05-05, に上場 Other OTC, 時価総額 $1.08M.
PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States. The company focuses on developing bone marrow transplantation and other cancer treatment procedures to benefit companion animals that are diagnosed with lymphoma, other different types of cancers, and other diseases that are incurable. It has licensed a series of proprietary devices and compounds that would reduce suffering in animals with cancer. The company was formerly known as ABV Gold Inc. and changed its name to PharmaCom BioVet, Inc. in August 2008. PharmaCom BioVet, Inc. was incorporated in 1995 and is headquartered in Raleigh, North Carolina.
